R, B., Y, T., A, Y., PS, K., & FM, L. (2015). MenAfriVac as an Antitetanus Vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 61 Suppl 5, S570. https://doi.org/10.1093/cid/civ512
Chicago Style (17th ed.) CitationR, Borrow, Tang Y, Yakubu A, Kulkarni PS, and LaForce FM. "MenAfriVac as an Antitetanus Vaccine." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 61 Suppl 5 (2015): S570. https://doi.org/10.1093/cid/civ512.
MLA (9th ed.) CitationR, Borrow, et al. "MenAfriVac as an Antitetanus Vaccine." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 61 Suppl 5, 2015, p. S570, https://doi.org/10.1093/cid/civ512.